Goodbye Galapagos: chameleon company exits the island, rebrands as Lakefront

After a 12-month period that saw the Belgian biotech consider a spinout, swap out CEOs, and enter a three-way acquisition agreement involving Ouro Medicines, Galapagos now has a new moniker.